These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7980625)

  • 21. Hypoxia-selective antitumor agents. 8. Bis(nitroimidazolyl)alkanecarboxamides: a new class of hypoxia-selective cytotoxins and hypoxic cell radiosensitisers.
    Hay MP; Wilson WR; Moselen JW; Palmer BD; Denny WA
    J Med Chem; 1994 Feb; 37(3):381-91. PubMed ID: 8308864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxia-selective antitumor agents. 2. Electronic effects of 4-substituents on the mechanisms of cytotoxicity and metabolic stability of nitracrine derivatives.
    Wilson WR; Thompson LH; Anderson RF; Denny WA
    J Med Chem; 1989 Jan; 32(1):31-8. PubMed ID: 2909741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolism of bioreductive antitumor compounds by purified rat and human DT-diaphorases.
    Beall HD; Mulcahy RT; Siegel D; Traver RD; Gibson NW; Ross D
    Cancer Res; 1994 Jun; 54(12):3196-201. PubMed ID: 8205540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterocyclic mono-N-oxides with potential applications as bioreductive anti-tumour drugs: Part 1. 8-Alkylamino-substituted phenylimidazo [1,2-a] quinoxalines.
    Naylor MA; Stephens MA; Nolan J; Sutton B; Tocher JH; Fielden EM; Adams GE; Stratford IJ
    Anticancer Drug Des; 1993 Dec; 8(6):439-61. PubMed ID: 8286012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiosensitizing and toxic properties of quinoline and nitroquinoline complexes of platinum [PtCl2(NH3)quinoline].
    Skov KA; Adomat H; Doedee M; Farrell N
    Anticancer Drug Des; 1994 Apr; 9(2):103-17. PubMed ID: 8166927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxia-selective, enzymatic conversion of 6-nitroquinoline into a fluorescent helicene: pyrido[3,2-f]quinolino[6,5-c]cinnoline 3-oxide.
    Rajapakse A; Gates KS
    J Org Chem; 2012 Apr; 77(7):3531-7. PubMed ID: 22417220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxia-selective antitumor agents. 1. Relationships between structure, redox properties and hypoxia-selective cytotoxicity for 4-substituted derivatives of nitracrine.
    Wilson WR; Anderson RF; Denny WA
    J Med Chem; 1989 Jan; 32(1):23-30. PubMed ID: 2909736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-activity relationships of 1,2,4-benzotriazine 1,4-dioxides as hypoxia-selective analogues of tirapazamine.
    Hay MP; Gamage SA; Kovacs MS; Pruijn FB; Anderson RF; Patterson AV; Wilson WR; Brown JM; Denny WA
    J Med Chem; 2003 Jan; 46(1):169-82. PubMed ID: 12502371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of aromatic and tertiary amine N-oxides of acridine DNA intercalators as bioreductive drugs. Cytotoxicity, DNA binding, cellular uptake, and metabolism.
    Siim BG; Hicks KO; Pullen SM; van Zijl PL; Denny WA; Wilson WR
    Biochem Pharmacol; 2000 Oct; 60(7):969-78. PubMed ID: 10974206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxicity of nitrobenzene compounds towards isolated hepatocytes: dependence on reduction potential.
    O'Brien PJ; Wong WC; Silva J; Khan S
    Xenobiotica; 1990 Sep; 20(9):945-55. PubMed ID: 2238713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimization of the auxiliary ligand shell of Cobalt(III)(8-hydroxyquinoline) complexes as model hypoxia-selective radiation-activated prodrugs.
    Ahn GO; Ware DC; Denny WA; Wilson WR
    Radiat Res; 2004 Sep; 162(3):315-25. PubMed ID: 15333003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioreductive metabolism of AF-2[2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide] combined with 2-nitroimidazoles. Implications for use as hypoxic cell markers.
    Koch CJ; Giandomenico AR; Iyengar CW
    Biochem Pharmacol; 1993 Sep; 46(6):1029-36. PubMed ID: 8216345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxia-selective antitumor agents. 3. Relationships between structure and cytotoxicity against cultured tumor cells for substituted N,N-bis(2-chloroethyl)anilines.
    Palmer BD; Wilson WR; Pullen SM; Denny WA
    J Med Chem; 1990 Jan; 33(1):112-21. PubMed ID: 2296009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of hypoxic and aerobic cytotoxicity of mitomycin C in Chinese hamster V79 cells.
    Krishna MC; DeGraff W; Tamura S; Gonzalez FJ; Samuni A; Russo A; Mitchell JB
    Cancer Res; 1991 Dec; 51(24):6622-8. PubMed ID: 1660344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Penetration of AF-2 and 4NQO into multicell spheroids.
    Olive PL; Durand RE
    Environ Mutagen; 1983; 5(4):553-63. PubMed ID: 6409603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caffeine inhibition of the metabolic activation of a carcinogen, 4-nitroquinoline-1-oxide, in cultured Chinese hamster cells.
    Tsuda H; Yoshida D; Mizusaki S
    Carcinogenesis; 1984 Mar; 5(3):331-4. PubMed ID: 6200248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radicals from one-electron reduction of nitro compounds, aromatic N-oxides and quinones: the kinetic basis for hypoxia-selective, bioreductive drugs.
    Wardman P; Dennis MF; Everett SA; Patel KB; Stratford MR; Tracy M
    Biochem Soc Symp; 1995; 61():171-94. PubMed ID: 8660394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective toxicity of nitracrine to hypoxic mammalian cells.
    Wilson WR; Denny WA; Twigden SJ; Baguley BC; Probert JC
    Br J Cancer; 1984 Feb; 49(2):215-23. PubMed ID: 6696822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of mutations in V79-4 mammalian cells under hypoxic and aerobic conditions by the cytotoxic 2-nitroimidazole-aziridines, RSU-1069 and RSU-1131. The influence of cellular glutathione.
    Sapora O; Paone A; Maggi A; Jenner TJ; O'Neill P
    Biochem Pharmacol; 1992 Oct; 44(7):1341-7. PubMed ID: 1417957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.